The report released by the advisory council on Wednesday recommended a $15-billion universal single-payer pharmacare program.

Drug companies offered to forego revenue and freeze prices ahead of a planned crackdown on Canadian prescription drug prices, documents show.

A new study says up to a billion dollars could be saved by making some common drugs available over-the-counter, instead of requiring a prescription. But experts say it's not worth the risk.